Return to program book search
Hidradenitis Suppurativa: An Update
Monday, March 24
Mile High Ballroom 3B
10:00 AM - 12:00 PM
Robert A. Lee, MD, PhD, FAAD
- F. William Danby, MD, FAAD - Handout
- Paul Gregory Hazen, MD, FAAD
- Gregor B.E. Jemec, MD
Following this course, the attendee should be able to:
- Diagnose hidradenitis suppurativa, differentiate it from clinical simulators and categorize it based on severity.
- Summarize current medical and surgical therapeutic options.
- Formulate and prescribe a treatment plan based on current medical literature.
Hidradenitis suppurativa is a chronic, recurrent, scarring inflammatory dermatosis. It is a common disease that is associated with considerable morbidity and often poses significant challenges for the practitioner. Its clinical presentation and corresponding histopathology will be reviewed. Standard and newer therapeutic options, including hormone therapy, immunomodulators, surgical and laser procedures, will be discussed. After this presentation, the audience will be able to diagnose and accurately stage the disease, describe its natural history, and summarize current therapies. They will be able to apply this information to develop a rational treatment algorithm for this often difficult to treat disease.
|Monday, March 24|
|10:00 AM||Hidradenitis Suppurativa: Introduction / Dr. Lee|
|10:05 AM||Hidradenitis Suppurativa: Overview and Pathophysiology / Dr. Danby|
|10:35 AM||Hidradenitis Suppurativa: Medical Management / Dr. Jemec|
|11:10 AM||Hidradenitis Suppurativa: Surgical Management / Dr. Hazen|
|11:45 AM||Q & A Discussion / All faculty|